Omar Guerra, MD
Surgery · Saint Louis, MONPI 1952337222
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $153,773 of the $249,282 with a category attached, or 61.7%. AbbVie accounts for 99.6% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $64,979 and has fallen 80.2% since, to $12,849 in 2025. Among surgery clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 287 payments — averaging $868.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$248K
- Intuitive Surgical$623
- Davol Inc.$122
- Johnson & Johnson$91
- W. L. Gore & Associates, Inc.$28
- Portola Pharmaceuticals, LLC$26
- plus $132 from 8 others
What the payments were for
- Consulting fees$71,22529%
- Speaking & faculty fees$153,77362%
- Travel & lodging$20,6288%
- Food & beverage$3,1551%
- Education$5020%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 254 | $248,260 |
| Intuitive Surgical | 11 | $623 |
| Davol Inc. | 6 | $122 |
| Johnson & Johnson(2 entities) | 4 | $91 |
| W. L. Gore & Associates, Inc. | 2 | $28 |
| Portola Pharmaceuticals, LLC | 1 | $26 |
| Cvrx, Inc. | 1 | $24 |
| TELA Bio, Inc. | 2 | $23 |
| BD | 1 | $18 |
| Smith+Nephew | 1 | $16 |
| Aesculap, Inc. | 1 | $14 |
| Acell, Inc. | 1 | $13 |
| Cook Medical LLC | 1 | $12 |
| Shire North American Group Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$180,794
- STRATTICE$55,614
- NATRELLE SALINE-FILLED BREAST IMPLANTS$29,455
- REVOLVE$11,977
- NATRELLE$5,828
- ALLODERM$1,470
- Da Vinci Surgical System$274
How this compares
$249,282 in reported general payments places this provider in the 95th percentile of 612 surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 205 | $996 |
Paid to pharmacies, not to this prescriber.
Other surgery in Saint Louis
- James ScottSaint Louis$307K
- Mark DrakeSaint Louis$212K
- Adeel KhanSaint Louis$204K
- Michael AwadSaint Louis$176K
- Laurie PunchSaint Louis$141K
- Jeffrey BlatnikSaint Louis$134K
- Sekhar DharmarajanSaint Louis$110K
- Shaina EckhouseSaint Louis$67K
- Jason RheeSaint Louis$63K
- Christopher LawranceSaint Louis$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.